论文部分内容阅读
甲胎蛋白(AFP)是临床上诊断肝细胞癌几乎惟一可用的血清标志物,其诊断准确率并不理想;高尔基体糖蛋白73(GP73)是当前被认为是肝细胞癌早期诊断的一个新的血清学肿瘤标志物。笔者就GP73及AFP两种肿瘤标记物的联合检测对肝细胞癌早期诊断和复发监测的应用价值的研究进展进行综述。
Alpha-fetoprotein (AFP) is the only clinically useful serum marker for hepatocellular carcinoma, and the diagnostic accuracy is not satisfactory. Golgi glycoprotein 73 (GP73) is currently considered as a new early diagnosis of hepatocellular carcinoma Serological tumor markers. The author of GP73 and AFP two tumor markers combined detection of hepatocellular carcinoma early diagnosis and recurrence monitoring the value of the research are reviewed.